nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—CYP1A2—type 2 diabetes mellitus	0.263	0.602	CbGaD
Pyrazinamide—CYP3A4—type 2 diabetes mellitus	0.174	0.398	CbGaD
Pyrazinamide—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0396	0.113	CbGbCtD
Pyrazinamide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0349	0.0999	CbGbCtD
Pyrazinamide—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0312	0.0893	CbGbCtD
Pyrazinamide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0311	0.089	CbGbCtD
Pyrazinamide—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0295	0.0844	CbGbCtD
Pyrazinamide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0284	0.0814	CbGbCtD
Pyrazinamide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0248	0.0712	CbGbCtD
Pyrazinamide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0225	0.0644	CbGbCtD
Pyrazinamide—CYP1A2—Losartan—type 2 diabetes mellitus	0.0201	0.0575	CbGbCtD
Pyrazinamide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.017	0.0488	CbGbCtD
Pyrazinamide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0163	0.0468	CbGbCtD
Pyrazinamide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0163	0.0468	CbGbCtD
Pyrazinamide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0154	0.0442	CbGbCtD
Pyrazinamide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0115	0.0329	CbGbCtD
Pyrazinamide—CYP3A4—Losartan—type 2 diabetes mellitus	0.0105	0.0301	CbGbCtD
Pyrazinamide—Arthralgia—Glipizide—type 2 diabetes mellitus	0.000447	0.00317	CcSEcCtD
Pyrazinamide—Myalgia—Glipizide—type 2 diabetes mellitus	0.000447	0.00317	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Rosiglitazone—type 2 diabetes mellitus	0.000446	0.00316	CcSEcCtD
Pyrazinamide—Discomfort—Glipizide—type 2 diabetes mellitus	0.000442	0.00313	CcSEcCtD
Pyrazinamide—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000441	0.00313	CcSEcCtD
Pyrazinamide—Malaise—Sitagliptin—type 2 diabetes mellitus	0.000441	0.00312	CcSEcCtD
Pyrazinamide—Photosensitivity—Ramipril—type 2 diabetes mellitus	0.000437	0.0031	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Valsartan—type 2 diabetes mellitus	0.000437	0.0031	CcSEcCtD
Pyrazinamide—Arthralgia—Pioglitazone—type 2 diabetes mellitus	0.000429	0.00304	CcSEcCtD
Pyrazinamide—Myalgia—Pioglitazone—type 2 diabetes mellitus	0.000429	0.00304	CcSEcCtD
Pyrazinamide—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000424	0.003	CcSEcCtD
Pyrazinamide—Discomfort—Pioglitazone—type 2 diabetes mellitus	0.000423	0.003	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.000423	0.003	CcSEcCtD
Pyrazinamide—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000422	0.00299	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.00042	0.00298	CcSEcCtD
Pyrazinamide—Hepatitis—Gliclazide—type 2 diabetes mellitus	0.000417	0.00296	CcSEcCtD
Pyrazinamide—Myalgia—Sitagliptin—type 2 diabetes mellitus	0.000416	0.00295	CcSEcCtD
Pyrazinamide—Arthralgia—Sitagliptin—type 2 diabetes mellitus	0.000416	0.00295	CcSEcCtD
Pyrazinamide—Urticaria—Repaglinide—type 2 diabetes mellitus	0.000412	0.00292	CcSEcCtD
Pyrazinamide—Discomfort—Sitagliptin—type 2 diabetes mellitus	0.000411	0.00291	CcSEcCtD
Pyrazinamide—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000411	0.00291	CcSEcCtD
Pyrazinamide—Anorexia—Glipizide—type 2 diabetes mellitus	0.000409	0.0029	CcSEcCtD
Pyrazinamide—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000408	0.00289	CcSEcCtD
Pyrazinamide—Rash—Tolazamide—type 2 diabetes mellitus	0.000408	0.00289	CcSEcCtD
Pyrazinamide—Rash—Linagliptin—type 2 diabetes mellitus	0.000403	0.00286	CcSEcCtD
Pyrazinamide—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000403	0.00286	CcSEcCtD
Pyrazinamide—Vomiting—Acarbose—type 2 diabetes mellitus	0.000395	0.0028	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.000392	0.00278	CcSEcCtD
Pyrazinamide—Rash—Acarbose—type 2 diabetes mellitus	0.000392	0.00278	CcSEcCtD
Pyrazinamide—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000391	0.00277	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.000391	0.00277	CcSEcCtD
Pyrazinamide—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000389	0.00276	CcSEcCtD
Pyrazinamide—Nausea—Tolazamide—type 2 diabetes mellitus	0.000384	0.00272	CcSEcCtD
Pyrazinamide—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000384	0.00272	CcSEcCtD
Pyrazinamide—Hepatitis—Valsartan—type 2 diabetes mellitus	0.000383	0.00272	CcSEcCtD
Pyrazinamide—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000382	0.00271	CcSEcCtD
Pyrazinamide—Anorexia—Glimepiride—type 2 diabetes mellitus	0.000381	0.0027	CcSEcCtD
Pyrazinamide—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000381	0.0027	CcSEcCtD
Pyrazinamide—Hepatitis—Orlistat—type 2 diabetes mellitus	0.000379	0.00268	CcSEcCtD
Pyrazinamide—Rash—Nateglinide—type 2 diabetes mellitus	0.000378	0.00268	CcSEcCtD
Pyrazinamide—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000377	0.00268	CcSEcCtD
Pyrazinamide—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000377	0.00267	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	0.000376	0.00266	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.000374	0.00265	CcSEcCtD
Pyrazinamide—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000373	0.00264	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.00037	0.00262	CcSEcCtD
Pyrazinamide—Nausea—Acarbose—type 2 diabetes mellitus	0.000369	0.00261	CcSEcCtD
Pyrazinamide—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000367	0.0026	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000363	0.00258	CcSEcCtD
Pyrazinamide—Nausea—Nateglinide—type 2 diabetes mellitus	0.000356	0.00252	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000355	0.00251	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000353	0.00251	CcSEcCtD
Pyrazinamide—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000353	0.0025	CcSEcCtD
Pyrazinamide—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000352	0.0025	CcSEcCtD
Pyrazinamide—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000351	0.00249	CcSEcCtD
Pyrazinamide—Hepatitis—Metformin—type 2 diabetes mellitus	0.000349	0.00247	CcSEcCtD
Pyrazinamide—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000348	0.00247	CcSEcCtD
Pyrazinamide—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000347	0.00246	CcSEcCtD
Pyrazinamide—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000347	0.00246	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000345	0.00245	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000344	0.00244	CcSEcCtD
Pyrazinamide—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000344	0.00244	CcSEcCtD
Pyrazinamide—Myalgia—Glyburide—type 2 diabetes mellitus	0.000344	0.00244	CcSEcCtD
Pyrazinamide—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000344	0.00244	CcSEcCtD
Pyrazinamide—Urticaria—Glipizide—type 2 diabetes mellitus	0.000341	0.00241	CcSEcCtD
Pyrazinamide—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000339	0.0024	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.000337	0.00239	CcSEcCtD
Pyrazinamide—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.00033	0.00234	CcSEcCtD
Pyrazinamide—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00033	0.00234	CcSEcCtD
Pyrazinamide—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000329	0.00233	CcSEcCtD
Pyrazinamide—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000329	0.00233	CcSEcCtD
Pyrazinamide—Malaise—Gliclazide—type 2 diabetes mellitus	0.000327	0.00232	CcSEcCtD
Pyrazinamide—Rash—Repaglinide—type 2 diabetes mellitus	0.000327	0.00232	CcSEcCtD
Pyrazinamide—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000326	0.00231	CcSEcCtD
Pyrazinamide—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000326	0.00231	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000323	0.00229	CcSEcCtD
Pyrazinamide—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000318	0.00225	CcSEcCtD
Pyrazinamide—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000318	0.00225	CcSEcCtD
Pyrazinamide—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000317	0.00225	CcSEcCtD
Pyrazinamide—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000316	0.00224	CcSEcCtD
Pyrazinamide—Anorexia—Glyburide—type 2 diabetes mellitus	0.000315	0.00223	CcSEcCtD
Pyrazinamide—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000314	0.00222	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000312	0.00221	CcSEcCtD
Pyrazinamide—Hepatitis—Losartan—type 2 diabetes mellitus	0.00031	0.0022	CcSEcCtD
Pyrazinamide—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000309	0.00219	CcSEcCtD
Pyrazinamide—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000309	0.00219	CcSEcCtD
Pyrazinamide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000309	0.00219	CcSEcCtD
Pyrazinamide—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000309	0.00219	CcSEcCtD
Pyrazinamide—Nausea—Repaglinide—type 2 diabetes mellitus	0.000308	0.00218	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000306	0.00217	CcSEcCtD
Pyrazinamide—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000305	0.00216	CcSEcCtD
Pyrazinamide—Pruritus—Glipizide—type 2 diabetes mellitus	0.000303	0.00215	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000303	0.00215	CcSEcCtD
Pyrazinamide—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000303	0.00215	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000301	0.00213	CcSEcCtD
Pyrazinamide—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000297	0.00211	CcSEcCtD
Pyrazinamide—Malaise—Orlistat—type 2 diabetes mellitus	0.000297	0.00211	CcSEcCtD
Pyrazinamide—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000295	0.00209	CcSEcCtD
Pyrazinamide—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000294	0.00208	CcSEcCtD
Pyrazinamide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000291	0.00206	CcSEcCtD
Pyrazinamide—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000291	0.00206	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00029	0.00206	CcSEcCtD
Pyrazinamide—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000287	0.00203	CcSEcCtD
Pyrazinamide—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000287	0.00203	CcSEcCtD
Pyrazinamide—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000285	0.00202	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000285	0.00202	CcSEcCtD
Pyrazinamide—Myalgia—Valsartan—type 2 diabetes mellitus	0.000284	0.00201	CcSEcCtD
Pyrazinamide—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000284	0.00201	CcSEcCtD
Pyrazinamide—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000283	0.00201	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000282	0.002	CcSEcCtD
Pyrazinamide—Myalgia—Orlistat—type 2 diabetes mellitus	0.000281	0.00199	CcSEcCtD
Pyrazinamide—Discomfort—Orlistat—type 2 diabetes mellitus	0.000277	0.00197	CcSEcCtD
Pyrazinamide—Malaise—Metformin—type 2 diabetes mellitus	0.000274	0.00194	CcSEcCtD
Pyrazinamide—Vomiting—Glipizide—type 2 diabetes mellitus	0.000273	0.00193	CcSEcCtD
Pyrazinamide—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000272	0.00193	CcSEcCtD
Pyrazinamide—Rash—Glipizide—type 2 diabetes mellitus	0.00027	0.00192	CcSEcCtD
Pyrazinamide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00027	0.00191	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00027	0.00191	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000267	0.00189	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000266	0.00189	CcSEcCtD
Pyrazinamide—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000266	0.00188	CcSEcCtD
Pyrazinamide—Urticaria—Glyburide—type 2 diabetes mellitus	0.000262	0.00186	CcSEcCtD
Pyrazinamide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000261	0.00185	CcSEcCtD
Pyrazinamide—Anorexia—Valsartan—type 2 diabetes mellitus	0.00026	0.00184	CcSEcCtD
Pyrazinamide—Myalgia—Metformin—type 2 diabetes mellitus	0.000259	0.00183	CcSEcCtD
Pyrazinamide—Malaise—Irbesartan—type 2 diabetes mellitus	0.000259	0.00183	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000256	0.00181	CcSEcCtD
Pyrazinamide—Discomfort—Metformin—type 2 diabetes mellitus	0.000256	0.00181	CcSEcCtD
Pyrazinamide—Nausea—Glipizide—type 2 diabetes mellitus	0.000255	0.00181	CcSEcCtD
Pyrazinamide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000254	0.0018	CcSEcCtD
Pyrazinamide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000254	0.0018	CcSEcCtD
Pyrazinamide—Rash—Glimepiride—type 2 diabetes mellitus	0.000252	0.00179	CcSEcCtD
Pyrazinamide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000252	0.00179	CcSEcCtD
Pyrazinamide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000252	0.00178	CcSEcCtD
Pyrazinamide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000251	0.00178	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.00025	0.00177	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000248	0.00176	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000245	0.00174	CcSEcCtD
Pyrazinamide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000244	0.00173	CcSEcCtD
Pyrazinamide—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000244	0.00173	CcSEcCtD
Pyrazinamide—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000244	0.00173	CcSEcCtD
Pyrazinamide—Malaise—Losartan—type 2 diabetes mellitus	0.000243	0.00172	CcSEcCtD
Pyrazinamide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000243	0.00172	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000243	0.00172	CcSEcCtD
Pyrazinamide—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000241	0.00171	CcSEcCtD
Pyrazinamide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00024	0.0017	CcSEcCtD
Pyrazinamide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000238	0.00168	CcSEcCtD
Pyrazinamide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000237	0.00168	CcSEcCtD
Pyrazinamide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000237	0.00168	CcSEcCtD
Pyrazinamide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000237	0.00168	CcSEcCtD
Pyrazinamide—Anorexia—Metformin—type 2 diabetes mellitus	0.000236	0.00168	CcSEcCtD
Pyrazinamide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000235	0.00167	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000235	0.00167	CcSEcCtD
Pyrazinamide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000234	0.00166	CcSEcCtD
Pyrazinamide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000234	0.00166	CcSEcCtD
Pyrazinamide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000233	0.00165	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000232	0.00165	CcSEcCtD
Pyrazinamide—Arthralgia—Losartan—type 2 diabetes mellitus	0.00023	0.00163	CcSEcCtD
Pyrazinamide—Myalgia—Losartan—type 2 diabetes mellitus	0.00023	0.00163	CcSEcCtD
Pyrazinamide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00023	0.00163	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000229	0.00162	CcSEcCtD
Pyrazinamide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000228	0.00161	CcSEcCtD
Pyrazinamide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000227	0.00161	CcSEcCtD
Pyrazinamide—Discomfort—Losartan—type 2 diabetes mellitus	0.000227	0.00161	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000226	0.0016	CcSEcCtD
Pyrazinamide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000223	0.00158	CcSEcCtD
Pyrazinamide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000222	0.00157	CcSEcCtD
Pyrazinamide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000218	0.00155	CcSEcCtD
Pyrazinamide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000218	0.00155	CcSEcCtD
Pyrazinamide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000216	0.00153	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000216	0.00153	CcSEcCtD
Pyrazinamide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000216	0.00153	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000215	0.00152	CcSEcCtD
Pyrazinamide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000214	0.00152	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000214	0.00152	CcSEcCtD
Pyrazinamide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000214	0.00151	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000213	0.00151	CcSEcCtD
Pyrazinamide—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000213	0.00151	CcSEcCtD
Pyrazinamide—Anorexia—Losartan—type 2 diabetes mellitus	0.00021	0.00149	CcSEcCtD
Pyrazinamide—Vomiting—Glyburide—type 2 diabetes mellitus	0.00021	0.00149	CcSEcCtD
Pyrazinamide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00021	0.00149	CcSEcCtD
Pyrazinamide—Malaise—Ramipril—type 2 diabetes mellitus	0.000209	0.00148	CcSEcCtD
Pyrazinamide—Rash—Glyburide—type 2 diabetes mellitus	0.000208	0.00147	CcSEcCtD
Pyrazinamide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000208	0.00147	CcSEcCtD
Pyrazinamide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000206	0.00146	CcSEcCtD
Pyrazinamide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000204	0.00145	CcSEcCtD
Pyrazinamide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000203	0.00144	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000202	0.00143	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000201	0.00142	CcSEcCtD
Pyrazinamide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000201	0.00142	CcSEcCtD
Pyrazinamide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000198	0.0014	CcSEcCtD
Pyrazinamide—Urticaria—Metformin—type 2 diabetes mellitus	0.000197	0.0014	CcSEcCtD
Pyrazinamide—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000197	0.0014	CcSEcCtD
Pyrazinamide—Myalgia—Ramipril—type 2 diabetes mellitus	0.000197	0.0014	CcSEcCtD
Pyrazinamide—Nausea—Glyburide—type 2 diabetes mellitus	0.000196	0.00139	CcSEcCtD
Pyrazinamide—Discomfort—Ramipril—type 2 diabetes mellitus	0.000195	0.00138	CcSEcCtD
Pyrazinamide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000194	0.00137	CcSEcCtD
Pyrazinamide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000193	0.00137	CcSEcCtD
Pyrazinamide—Pruritus—Valsartan—type 2 diabetes mellitus	0.000193	0.00137	CcSEcCtD
Pyrazinamide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000191	0.00136	CcSEcCtD
Pyrazinamide—Pruritus—Orlistat—type 2 diabetes mellitus	0.00019	0.00135	CcSEcCtD
Pyrazinamide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000188	0.00134	CcSEcCtD
Pyrazinamide—Rash—Gliclazide—type 2 diabetes mellitus	0.000187	0.00132	CcSEcCtD
Pyrazinamide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000187	0.00132	CcSEcCtD
Pyrazinamide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000186	0.00132	CcSEcCtD
Pyrazinamide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000185	0.00131	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000185	0.00131	CcSEcCtD
Pyrazinamide—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000181	0.00129	CcSEcCtD
Pyrazinamide—Anorexia—Ramipril—type 2 diabetes mellitus	0.00018	0.00128	CcSEcCtD
Pyrazinamide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000176	0.00125	CcSEcCtD
Pyrazinamide—Pruritus—Metformin—type 2 diabetes mellitus	0.000175	0.00124	CcSEcCtD
Pyrazinamide—Urticaria—Losartan—type 2 diabetes mellitus	0.000175	0.00124	CcSEcCtD
Pyrazinamide—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000174	0.00123	CcSEcCtD
Pyrazinamide—Vomiting—Valsartan—type 2 diabetes mellitus	0.000173	0.00123	CcSEcCtD
Pyrazinamide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000172	0.00122	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000172	0.00122	CcSEcCtD
Pyrazinamide—Rash—Valsartan—type 2 diabetes mellitus	0.000172	0.00122	CcSEcCtD
Pyrazinamide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000172	0.00122	CcSEcCtD
Pyrazinamide—Vomiting—Orlistat—type 2 diabetes mellitus	0.000171	0.00121	CcSEcCtD
Pyrazinamide—Rash—Orlistat—type 2 diabetes mellitus	0.00017	0.0012	CcSEcCtD
Pyrazinamide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000169	0.0012	CcSEcCtD
Pyrazinamide—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000166	0.00118	CcSEcCtD
Pyrazinamide—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000166	0.00117	CcSEcCtD
Pyrazinamide—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000164	0.00116	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000163	0.00116	CcSEcCtD
Pyrazinamide—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000162	0.00115	CcSEcCtD
Pyrazinamide—Nausea—Valsartan—type 2 diabetes mellitus	0.000162	0.00115	CcSEcCtD
Pyrazinamide—Nausea—Orlistat—type 2 diabetes mellitus	0.00016	0.00113	CcSEcCtD
Pyrazinamide—Vomiting—Metformin—type 2 diabetes mellitus	0.000158	0.00112	CcSEcCtD
Pyrazinamide—Rash—Metformin—type 2 diabetes mellitus	0.000156	0.00111	CcSEcCtD
Pyrazinamide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000156	0.00111	CcSEcCtD
Pyrazinamide—Pruritus—Losartan—type 2 diabetes mellitus	0.000156	0.0011	CcSEcCtD
Pyrazinamide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000156	0.0011	CcSEcCtD
Pyrazinamide—Urticaria—Ramipril—type 2 diabetes mellitus	0.00015	0.00106	CcSEcCtD
Pyrazinamide—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000149	0.00106	CcSEcCtD
Pyrazinamide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000149	0.00105	CcSEcCtD
Pyrazinamide—Rash—Irbesartan—type 2 diabetes mellitus	0.000148	0.00105	CcSEcCtD
Pyrazinamide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000147	0.00104	CcSEcCtD
Pyrazinamide—Nausea—Metformin—type 2 diabetes mellitus	0.000147	0.00104	CcSEcCtD
Pyrazinamide—Vomiting—Losartan—type 2 diabetes mellitus	0.00014	0.000992	CcSEcCtD
Pyrazinamide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000139	0.000986	CcSEcCtD
Pyrazinamide—Nausea—Irbesartan—type 2 diabetes mellitus	0.000139	0.000985	CcSEcCtD
Pyrazinamide—Rash—Losartan—type 2 diabetes mellitus	0.000139	0.000984	CcSEcCtD
Pyrazinamide—Dermatitis—Losartan—type 2 diabetes mellitus	0.000139	0.000983	CcSEcCtD
Pyrazinamide—Pruritus—Ramipril—type 2 diabetes mellitus	0.000134	0.000947	CcSEcCtD
Pyrazinamide—Nausea—Losartan—type 2 diabetes mellitus	0.000131	0.000927	CcSEcCtD
Pyrazinamide—Vomiting—Ramipril—type 2 diabetes mellitus	0.00012	0.000851	CcSEcCtD
Pyrazinamide—Rash—Ramipril—type 2 diabetes mellitus	0.000119	0.000844	CcSEcCtD
Pyrazinamide—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000119	0.000843	CcSEcCtD
Pyrazinamide—Nausea—Ramipril—type 2 diabetes mellitus	0.000112	0.000795	CcSEcCtD
Pyrazinamide—AOX1—Disease—MTHFR—type 2 diabetes mellitus	2.88e-05	0.000398	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	2.85e-05	0.000394	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—APOB—type 2 diabetes mellitus	2.8e-05	0.000387	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HIF1A—type 2 diabetes mellitus	2.74e-05	0.000379	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IRS2—type 2 diabetes mellitus	2.74e-05	0.000378	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.73e-05	0.000378	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GNB3—type 2 diabetes mellitus	2.73e-05	0.000378	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTM1—type 2 diabetes mellitus	2.73e-05	0.000377	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—HMOX1—type 2 diabetes mellitus	2.72e-05	0.000376	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CALM1—type 2 diabetes mellitus	2.69e-05	0.000372	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CAT—type 2 diabetes mellitus	2.69e-05	0.000371	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—APOE—type 2 diabetes mellitus	2.68e-05	0.00037	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—LPL—type 2 diabetes mellitus	2.68e-05	0.00037	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—APOA1—type 2 diabetes mellitus	2.65e-05	0.000366	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ADCY5—type 2 diabetes mellitus	2.62e-05	0.000362	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GPX1—type 2 diabetes mellitus	2.61e-05	0.000361	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOB—type 2 diabetes mellitus	2.61e-05	0.00036	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CD36—type 2 diabetes mellitus	2.54e-05	0.000351	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTM1—type 2 diabetes mellitus	2.54e-05	0.00035	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.51e-05	0.000347	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOS2—type 2 diabetes mellitus	2.5e-05	0.000345	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—LPL—type 2 diabetes mellitus	2.49e-05	0.000344	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ADCY5—type 2 diabetes mellitus	2.44e-05	0.000337	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GPX1—type 2 diabetes mellitus	2.43e-05	0.000335	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	2.42e-05	0.000335	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	2.42e-05	0.000335	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—MTHFR—type 2 diabetes mellitus	2.41e-05	0.000333	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.41e-05	0.000333	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IRS1—type 2 diabetes mellitus	2.39e-05	0.00033	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—BHMT—type 2 diabetes mellitus	2.38e-05	0.000329	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.37e-05	0.000328	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CD36—type 2 diabetes mellitus	2.36e-05	0.000327	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PPARA—type 2 diabetes mellitus	2.36e-05	0.000327	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PPP2CA—type 2 diabetes mellitus	2.34e-05	0.000323	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AGT—type 2 diabetes mellitus	2.29e-05	0.000316	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—INS—type 2 diabetes mellitus	2.29e-05	0.000316	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CALM1—type 2 diabetes mellitus	2.25e-05	0.000311	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—APOE—type 2 diabetes mellitus	2.24e-05	0.00031	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—MTHFR—type 2 diabetes mellitus	2.24e-05	0.00031	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—APOA1—type 2 diabetes mellitus	2.22e-05	0.000306	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKT2—type 2 diabetes mellitus	2.21e-05	0.000306	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PPARA—type 2 diabetes mellitus	2.2e-05	0.000304	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AGT—type 2 diabetes mellitus	2.13e-05	0.000294	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SERPINE1—type 2 diabetes mellitus	2.1e-05	0.00029	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CALM1—type 2 diabetes mellitus	2.09e-05	0.000289	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOE—type 2 diabetes mellitus	2.09e-05	0.000288	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AANAT—type 2 diabetes mellitus	2.08e-05	0.000287	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTGDS—type 2 diabetes mellitus	2.08e-05	0.000287	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOA1—type 2 diabetes mellitus	2.06e-05	0.000285	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3R1—type 2 diabetes mellitus	2.01e-05	0.000277	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOS3—type 2 diabetes mellitus	2.01e-05	0.000277	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.98e-05	0.000273	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	1.97e-05	0.000272	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	1.97e-05	0.000272	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PPARG—type 2 diabetes mellitus	1.95e-05	0.00027	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.93e-05	0.000266	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—INS—type 2 diabetes mellitus	1.92e-05	0.000265	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.91e-05	0.000264	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	1.88e-05	0.00026	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.86e-05	0.000257	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTGS2—type 2 diabetes mellitus	1.84e-05	0.000254	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.84e-05	0.000254	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PPARG—type 2 diabetes mellitus	1.82e-05	0.000251	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—INS—type 2 diabetes mellitus	1.78e-05	0.000246	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALB—type 2 diabetes mellitus	1.76e-05	0.000243	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	1.74e-05	0.00024	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	1.74e-05	0.00024	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.73e-05	0.000239	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.7e-05	0.000234	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NOS3—type 2 diabetes mellitus	1.68e-05	0.000232	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.68e-05	0.000232	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.68e-05	0.000232	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.68e-05	0.000232	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	1.68e-05	0.000232	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	1.68e-05	0.000232	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	1.68e-05	0.000232	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	1.68e-05	0.000232	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALB—type 2 diabetes mellitus	1.63e-05	0.000226	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	1.62e-05	0.000224	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.6e-05	0.000222	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.6e-05	0.000222	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3R1—type 2 diabetes mellitus	1.56e-05	0.000216	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NOS3—type 2 diabetes mellitus	1.56e-05	0.000216	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTGS2—type 2 diabetes mellitus	1.54e-05	0.000212	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	1.53e-05	0.000212	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	1.53e-05	0.000212	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.52e-05	0.00021	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.52e-05	0.00021	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	1.49e-05	0.000206	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SRC—type 2 diabetes mellitus	1.48e-05	0.000205	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.45e-05	0.0002	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTGS2—type 2 diabetes mellitus	1.43e-05	0.000197	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	1.42e-05	0.000197	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	1.42e-05	0.000197	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	1.42e-05	0.000197	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	1.37e-05	0.000189	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	1.37e-05	0.000189	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.34e-05	0.000185	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.34e-05	0.000185	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TGFB1—type 2 diabetes mellitus	1.33e-05	0.000183	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.31e-05	0.000182	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	1.31e-05	0.000182	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—EGFR—type 2 diabetes mellitus	1.3e-05	0.00018	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.29e-05	0.000179	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.29e-05	0.000179	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.29e-05	0.000179	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.29e-05	0.000179	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.29e-05	0.000179	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	1.29e-05	0.000178	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.29e-05	0.000178	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	1.27e-05	0.000175	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	1.27e-05	0.000175	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.27e-05	0.000175	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.25e-05	0.000173	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.23e-05	0.00017	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	1.19e-05	0.000165	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.18e-05	0.000163	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.18e-05	0.000163	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.18e-05	0.000162	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.15e-05	0.000159	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.15e-05	0.000158	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	1.12e-05	0.000154	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.12e-05	0.000154	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.1e-05	0.000152	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.1e-05	0.000152	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.1e-05	0.000152	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	1.08e-05	0.000149	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	1.08e-05	0.000149	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	1.08e-05	0.000149	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	1.08e-05	0.000149	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.05e-05	0.000146	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.05e-05	0.000146	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.04e-05	0.000143	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	1.04e-05	0.000143	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.01e-05	0.00014	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.01e-05	0.00014	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.01e-05	0.000139	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6—type 2 diabetes mellitus	1e-05	0.000138	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	9.97e-06	0.000138	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.85e-06	0.000136	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	9.8e-06	0.000135	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	9.8e-06	0.000135	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	9.8e-06	0.000135	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.74e-06	0.000135	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	9.62e-06	0.000133	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKT1—type 2 diabetes mellitus	9.23e-06	0.000127	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	9.22e-06	0.000127	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	8.99e-06	0.000124	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	8.8e-06	0.000122	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	8.8e-06	0.000122	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	8.63e-06	0.000119	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	8.63e-06	0.000119	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.58e-06	0.000119	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	8.58e-06	0.000119	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	8.58e-06	0.000119	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	8.58e-06	0.000119	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	8.53e-06	0.000118	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	8.37e-06	0.000116	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	8.33e-06	0.000115	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	8.33e-06	0.000115	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	8.33e-06	0.000115	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	8.33e-06	0.000115	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	8.28e-06	0.000114	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	7.99e-06	0.00011	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AKT1—type 2 diabetes mellitus	7.73e-06	0.000107	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.72e-06	0.000107	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	7.69e-06	0.000106	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	7.69e-06	0.000106	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	7.69e-06	0.000106	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	7.55e-06	0.000104	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	7.49e-06	0.000103	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	7.43e-06	0.000103	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.38e-06	0.000102	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	7.32e-06	0.000101	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AKT1—type 2 diabetes mellitus	7.18e-06	9.93e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	7.04e-06	9.72e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	6.96e-06	9.61e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.93e-06	9.58e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.79e-06	9.39e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.79e-06	9.39e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	6.79e-06	9.38e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.75e-06	9.33e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	6.67e-06	9.22e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	6.67e-06	9.22e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.66e-06	9.2e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.62e-06	9.15e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.62e-06	9.15e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.62e-06	9.15e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.58e-06	9.09e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.46e-06	8.93e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.39e-06	8.82e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.94e-06	8.2e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.94e-06	8.2e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.94e-06	8.2e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.83e-06	8.05e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.78e-06	7.98e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	5.75e-06	7.94e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.75e-06	7.94e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	5.72e-06	7.91e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.65e-06	7.81e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	5.65e-06	7.8e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	5.48e-06	7.57e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.43e-06	7.5e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.37e-06	7.42e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.37e-06	7.42e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	5.33e-06	7.37e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	5.24e-06	7.23e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.15e-06	7.11e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.15e-06	7.11e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	5.13e-06	7.08e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	5.11e-06	7.06e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.97e-06	6.87e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	4.91e-06	6.79e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	4.71e-06	6.51e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	4.62e-06	6.39e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	4.48e-06	6.19e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.44e-06	6.13e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.44e-06	6.13e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.42e-06	6.1e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	4.4e-06	6.08e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	4.39e-06	6.06e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.36e-06	6.02e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	4.34e-06	5.99e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.23e-06	5.85e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.12e-06	5.69e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.04e-06	5.58e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.96e-06	5.46e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.94e-06	5.45e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.84e-06	5.3e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.82e-06	5.28e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.79e-06	5.24e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.75e-06	5.18e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.64e-06	5.03e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.57e-06	4.93e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.46e-06	4.78e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	3.44e-06	4.75e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.4e-06	4.7e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.39e-06	4.68e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.35e-06	4.63e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	3.29e-06	4.54e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.29e-06	4.54e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	3.01e-06	4.15e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.95e-06	4.08e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.89e-06	4e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.65e-06	3.66e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.54e-06	3.51e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.54e-06	3.51e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.32e-06	3.21e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.51e-06	2.09e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.17e-06	1.61e-05	CbGpPWpGaD
